Tibet Rhodiola Pharmaceutical Holding Co.,Ltd.’s Net Profit Rose 11.2% in First Quarter of 2022

Tibet Rhodiola Pharmaceutical Holding Co.,Ltd. (西藏诺迪康药业股份有限公司) (600211.SH) reported a net profit of 176.2 million yuan in the first quarter of 2022, up 11.2% year-on-year.

Meanwhile, the company posted 656.1 million yuan in revenue, up 32.7% year-on-year.

At the end of the reporting period, it had 4 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 30.2%.